Skip to main content
SpringerLink
Log in

Sofosbuvir cost effective in certain HCV populations

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. San Miguel R, et al. Cost-effectiveness analysis of sofosbuvir-based regimens for chronic hepatitis C. Gut : 13 Oct 2014. Available from: URL: http://doi.org/10.1136/gutjnl-2014-307772

    PubMed  Google Scholar 

  2. Liu S, et al. Sofosbuvir-based treatment regimens for chronic, genotype 1 hepatitis C virus infection in u.s. Incarcerated populations: a cost-effectiveness analysis. Annals of Internal Medicine 161: 546-53, No. 8, 12 Oct 2014. Available from: URL: http://doi.org/10.7326/M14-0602

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sofosbuvir cost effective in certain HCV populations. PharmacoEcon Outcomes News 715, 27 (2014). https://doi.org/10.1007/s40274-014-1685-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1685-2

Search

Navigation